The Promise of a Malaria Vaccine - Are We Closer?

51Citations
Citations of this article
226Readers
Mendeley users who have this article in their library.

Abstract

Malaria vaccine development has rapidly advanced in the past decade. The very first phase 3 clinical trial of the RTS,S vaccine was completed with over 15,000 African infants and children, and pilot implementation studies are underway. Next-generation candidate vaccines using novel antigens, platforms, or approaches targeting different and/or multiple stages of the Plasmodium life cycle are being tested. Many candidates, in various stages of development, promise enhanced efficacy of long duration and broad protection against genetically diverse malaria strains, with a few studies under way in target populations in endemic areas. Malaria vaccines together with other interventions promise interruption and eventual elimination of malaria in endemic areas.

Cite

CITATION STYLE

APA

Laurens, M. B. (2018, September 8). The Promise of a Malaria Vaccine - Are We Closer? Annual Review of Microbiology. Annual Reviews Inc. https://doi.org/10.1146/annurev-micro-090817-062427

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free